Please login to the form below

Not currently logged in


This page shows the latest cost-effectiveness news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use

Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use

However, the UK's cost-effectiveness watchdog says the drug should only be used in limited circumstances for eosinophilic asthma, when usual therapies such as inhaled corticosteroids and beta-agonists fails

Latest news

More from news
Approximately 3 fully matching, plus 535 partially matching documents found.

Latest Intelligence

  • Shaping healthcare Shaping healthcare

    It’s a huge challenge. Germany and France aren’t easy either. They don’t do the cost-effectiveness approach, at least not with the same consequences as the UK, but ... their therapeutic effectiveness approaches also lead to very difficult

  • No incentive for a cure No incentive for a cure

    In August 2017, Novartis announced that Kymriah would be $475, 000 per treatment, which caused a lot of headlines, but was actually lower than many analysts were expecting; a cost-effectiveness ... Indeed, the cost-effectiveness evidence for many

  • Public relations

    Healthcare terms - Public relations.

  • Digital

    Healthcare terms - Digital.

  • Finance and investment

    Healthcare terms - Finance and investment.

More from intelligence
Approximately 0 fully matching, plus 51 partially matching documents found.

Latest appointments

  • Former NICE chair joins board of biotech Former NICE chair joins board of biotech

    The former chair of England's cost-effectiveness body for medicines, Sir Michael Rawlins, has made a contentious move to the US biotech Intra-Cellular Therapies as member of its board ... His expertise in the cost-effectiveness of new pharmaceuticals and

  • Executive changes at Teva as community and institutional affairs division launched

    Referencing Teva's previous record in compliance, Dr De Notaristefani said: “ We will continue this practice as we begin to set the industry standard for regulatory compliance, customer service and cost ... effectiveness.”. Teva launches community

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • The Heart of the Matter 7: Reality Dawns

    to use it to demonstrate effectiveness in the real-world setting,” says Mariam Bibi, director of realworld evidence, Complete True Life. “ ... It's all about making the right Connections.". Key Takeaways. HTA Bodies and regulators are placing an

  • Webinar: What next for biosimilars?

    Biosimilar medicines appear to present a significant opportunity to introduce cutting-edge therapies to the treatment landscape for many diseases, while also addressing the cost-effectiveness demands now being made on

  • Digital is different – why new marketing technologies require new ways of working

    More engaging materials? Better market understanding? More ROI? Cost-effectiveness? All those are great goals but there’ s one thing to demand of digital technology beyond all the others: individual relevancy.

  • Quality Personnel

    Quality Personnel. Established in 1987, Quality Personnel Services Limited set out to provide a reputation for quality, integrity and cost effectiveness.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....